Item 5.07 Submission of Matters to a Vote of Security Holders On June 8, 2021, ARYA Sciences Acquisition Corp III ("ARYA") held an extraordinary general meeting of its shareholders (the "General Meeting"), at which holders of 14,520,657 ordinary shares (consisting of 10,783,157 Class A ordinary shares and 3,737,500 Class B ordinary shares) held of record as of April 1, 2021, the record date for the General Meeting, were present in person or by proxy, representing 75.68% of the voting power of ARYA's ordinary shares as of the record date for the General Meeting, and constituting a quorum for the transaction of business. The proposals listed below are described in more detail in the definitive proxy statement/prospectus of ARYA, which was filed with the U.S. Securities and Exchange Commission (the "SEC") on May 14, 2021 (the "Proxy Statement"). A summary of the voting results at the General Meeting is set forth below: The shareholders approved the Business Combination Proposal, the Domestication Proposal, the Charter Proposal, each of the Advisory Governing Documents Proposals, the Nasdaq Proposal, the Incentive Award Plan Proposal and the Employee Stock Purchase Plan Proposal (each as defined in the Proxy Statement). The voting results for each proposal were as follows: The Business Combination Proposal


                              For            Against        Abstain
                           14,260,138        259,510         1,009

The Domestication Proposal


                              For            Against        Abstain
                           14,258,975        259,863         1,819


The Charter Proposal
                              For            Against        Abstain
                           14,259,527        259,386         1,744

Advisory Governing Documents Proposal A


                              For            Against        Abstain
                           13,023,998       1,490,878        5,781

Advisory Governing Documents Proposal B


                              For            Against        Abstain
                           12,332,550       2,185,433        2,674

Advisory Governing Documents Proposal C


                              For            Against        Abstain
                           12,335,448       2,180,745        4,464

Advisory Governing Documents Proposal D


                              For            Against        Abstain
                           13,034,002       1,484,156        2,499




--------------------------------------------------------------------------------


The Nasdaq Proposal
                              For            Against        Abstain
                           14,257,947        260,356         2,354

The Incentive Award Proposal


                              For            Against        Abstain
                           13,036,549       1,480,441        3,667

The Employee Stock Purchase Plan Proposal


                              For            Against        Abstain
                           14,251,808        265,454         3,395


As there were sufficient votes to approve the above proposals, the "Adjournment
Proposal" described in the Proxy Statement was not presented to shareholders.
Based on the results of the General Meeting, and subject to the satisfaction or
waiver of certain other closing conditions as described in the Proxy Statement,
the transactions (the "Transactions") contemplated by that certain Business
Combination Agreement (the "Business Combination Agreement"), dated as of
February 7, 2021, by and among ARYA, Mako Merger Sub, Inc. and Nautilus
Biotechnology, Inc. ("Nautilus"), including the Domestication and the Business
Combination (as such terms are defined in the Proxy Statement), are expected to
be consummated on June 9, 2021. Following the consummation of the Transactions,
the common stock of New Nautilus (as such term is defined in the Proxy
Statement) is expected to begin trading on the Nasdaq Capital Market under the
symbol "NAUT" on June 10, 2021.
Additional Information
ARYA has filed, and the SEC has declared effective, a Registration Statement on
Form S-4, containing the Proxy Statement relating to the proposed Business
Combination. ARYA has mailed the Proxy Statement and other relevant documents to
its shareholders of record. This communication is not a substitute for the Proxy
Statement or any other document that ARYA sent or will send to its shareholders
in connection with the Business Combination. Investors and security holders of
ARYA are advised to read the Proxy Statement in connection with ARYA's
solicitation of proxies for its extraordinary general meeting of shareholders to
be held to approve the Business Combination (and related matters) because the
Proxy Statement contains important information about the Business Combination
and the parties to the Business Combination.  Shareholders are also able to
obtain copies of the Proxy Statement, without charge, at the SEC's website at
www.sec.gov or by directing a request to: 51 Astor Place, 10th Floor, New York,
New York 10003.
Participants in the Solicitation
ARYA, Nautilus and their respective directors, executive officers, other members
of management, and employees, under SEC rules, may be deemed to be participants
in the solicitation of proxies of ARYA's shareholders in connection with the
Business Combination. A list of the names of those directors and executive
officers and a description of their interests in ARYA is contained in the Proxy
Statement, which was filed with the SEC and is available free of charge at the
SEC's website at www.sec.gov, or by directing a request to: 51 Astor Place, 10th
Floor, New York, New York 10003.
Forward Looking Statements
Certain statements made herein are not historical facts but are forward-looking
statements for purposes of the safe harbor provisions under The Private
Securities Litigation Reform Act of 1995. Forward-looking statements

--------------------------------------------------------------------------------

generally are accompanied by words such as "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect," "should," "would," "plan,"
"predict," "potential," "seem," "seek," "future," "outlook" and similar
expressions that predict or indicate future events or trends or that are not
statements of historical matters.
These forward-looking statements include, but are not limited to, statements
regarding future events, the Business Combination between ARYA and Nautilus, the
estimated or anticipated future results and benefits of the combined company
following the Business Combination, including the likelihood and ability of the
parties to successfully consummate the Business Combination, future
opportunities for the combined company, and other statements that are not
historical facts. These statements are based on the current expectations of
ARYA's management and are not predictions of actual performance. These
forward-looking statements are provided for illustrative purposes only and are
not intended to serve as, and must not be relied on, by any investor as a
guarantee, an assurance, a prediction or a definitive statement of fact or
probability. Actual events and circumstances are difficult or impossible to
predict and will differ from assumptions. Many actual events and circumstances
are beyond the control of Arya and Nautilus. These statements are subject to a
number of risks and uncertainties regarding ARYA's businesses and the Business
Combination, and actual results may differ materially. These risks and
uncertainties include, but are not limited to, general economic, political and
business conditions; the inability of the parties to consummate the Business
Combination or the occurrence of any event, change or other circumstances that
could give rise to the termination of the Business Combination Agreement; the
outcome of any legal proceedings that may be instituted against the parties
following the announcement of the Business Combination; the receipt of an
unsolicited offer from another party for an alternative business transaction
that could interfere with the Business Combination; failure to realize the
anticipated benefits of the Business Combination, including as a result of a
delay in consummating the potential transaction or difficulty in integrating the
businesses of ARYA and Nautilus; the risk that the Business Combination disrupts
current plans and operations as a result of the announcement and consummation of
the Business Combination; the ability of the combined company to grow and manage
growth profitably and retain its key employees; the amount of redemption
requests made by ARYA's shareholders; the inability to obtain or maintain the
listing of the post-acquisition company's securities on Nasdaq following the
Business Combination; costs related to the Business Combination; and those
factors discussed in ARYA's Proxy Statement relating to the Business Combination
or final prospectus relating to its initial public offering, dated August 6,
2020, and other filings with the SEC. There may be additional risks that ARYA
presently does not know or that ARYA currently believes are immaterial that
could also cause actual results to differ from those contained in the
forward-looking statements. In addition, forward-looking statements provide
ARYA's expectations, plans or forecasts of future events and views as of the
date of this communication. ARYA anticipates that subsequent events and
developments will cause ARYA's assessments to change. However, while ARYA may
elect to update these forward-looking statements at some point in the future,
ARYA specifically disclaims any obligation to do so. These forward-looking
statements should not be relied upon as representing ARYA's assessments as of
any date subsequent to the date of this communication. Accordingly, undue
reliance should not be placed upon the forward-looking statements.
Disclaimer
This communication is for informational purposes only and is neither an offer to
purchase, nor a solicitation of an offer to sell, subscribe for or buy any
securities or the solicitation of any vote in any jurisdiction pursuant to the
Business Combination or otherwise, nor shall there be any sale, issuance or
transfer or securities in any jurisdiction in contravention of applicable law.
No offer of securities shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as amended.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses